August 27, 2026
1 min read

Thyroid Tablets Recalled Nationwide Due To Potential Over-Potency Risk MedNews

THURSDAY, Aug. 27, 2026 More than 3,600 bottles of a common thyroid medication are being recalled nationwide because lab testing showed the pills could be too s

Leave a Reply

Your email address will not be published.

Previous Story

FDA Approves Rasonque, the First Pill To Extend Survival In Advanced Pancreatic Cancer MedNews

Next Story

BMS splashes out $173M to build 2nd radiopharmaceutical plant in Indiana

Previous Story

FDA Approves Rasonque, the First Pill To Extend Survival In Advanced Pancreatic Cancer MedNews

Next Story

BMS splashes out $173M to build 2nd radiopharmaceutical plant in Indiana

Latest from Blog

Go toTop